Invex Health is a dynamic healthcare company specialising in the distribution of a diverse portfolio of over 600 products across various sectors, including pharmaceuticals, nutraceuticals, dermo-cosmetics, and medical devices. Operating in regions such as Southeast Asia, Latin America, the Commonwealth of Independent States, North America, and Africa, Invex Health is supported by several prestigious manufacturing plant approvals, which include EU-GMP, PIC/S, UK-MHRA, WHO-GMP, T-FDA, NAFDAC, ANVISA, and INVIMA. The company’s therapeutic areas encompass oncology, biosimilars, cardiovascular health, anti-diabetics, dermatology, and neurology.

Services include:
- Anatomical Therapeutic Chemical (ATC) Classification
- Finished Dosage Forms
- Product Registration
- Tender Participation
- Technology Transfer
- Clinical Trial Supply

Invex Health is committed to delivering high-quality healthcare solutions and enhancing partnerships within the pharmaceutical industry. For more information, visit invexhealth.com.